“Save Blood Save Lives Save Money” - this is precisely the phrase that captures the endeavor undertaken by Werfen India in creating awareness towards Patient blood management as the country witnesses blood transfusions as one of the most overused treatment in modern medicine.
We are proud to have recently won a new customer, in a tender against Radiometer, at Hamad Medical Corporation (HMC), in Qatar. HMC manages 12 hospitals – nine specialty hospitals and three community hospitals – as well as the National Ambulance Service and home and residential care services.
The IL team has secured our first US contract for the new GEM Premier ChemSTAT system, and it is sizable at 15 units!
Our Werfen team in the UK recently accomplished a major milestone: the very first commercial placement of the new GEM Premier ChemSTAT analyzer in the Emergency Department (ED) at East Surrey Hospital. A 700-bed hospital, East Surrey is part of the Surrey and Sussex Healthcare, National Health Service Trust.
Institute of Liver and Biliary Sciences located in New Delhi is a first of its kind facility to offer complete liver and biliary treatment and is widely known as the best centre in India for liver disease management.
Werfen EEMEAI, together with our Greek partner Antisel, participated in the XVIIIth Congress of the European Shock Society
In continuation with our "Connecting Value" meeting in April in Rome, we wanted to share amazing news regarding Hemostasis, Autoimmunity and Acute Care Diagnostics Lines and our collective ability as part of the EEMEAI world to continuously Deliver Results.
The 6th EEMEAI meeting in Rome was the first time that ‘Critical Care’ marketing meeting transitioned to ‘Acute Care Diagnostics’. We witnessed the complete integration of ROTEM® and Accriva products in Werfen’s Acute Care Diagnostics portfolio together with GEM® Premier Family and GEMweb® Plus custom connectivity solution at strategic and operational levels.

